Impact of probiotic feeding during weaning on the serum lipid profile and plasma metabolome in infants

British Journal of Nutrition

Volumn 110, Issue 1, 2013, Pages 116-126

  Chorell, Elin ^a   Karlsson Videhult, Frida ^b   Hernell, Olle ^b   Antti, Henrik ^a   West, Christina E ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Infant feeding; Lactobacillus paracasei ssp. paracasei strain F19; Metabolomics; Probiotics

Indexed keywords

2 OXOISOCAPROIC ACID; ALANINE; ALCOHOL; AMINE; AMINO ACID; BUTYRIC ACID; CARBOHYDRATE; CARBOXYLIC ACID; ETHANOLAMINE; FATTY ACID; GLYCERIC ACID; GLYCEROL; GLYCINE; HYDROXYACID; LACTIC ACID; MONOUNSATURATED FATTY ACID; OXALIC ACID; PALMITOLEIC ACID; PHOSPHORIC ACID; PIPECOLIC ACID; PLACEBO; POLYOL; PROBIOTIC AGENT; PROLINE; PUTRESCINE; SERINE; SUCCINIC ACID; UREA; VALINE;

ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CEREAL; COLONY FORMING UNIT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEEDING; FEMALE; FOOD INTAKE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFANT; LACTOBACILLUS PARACASEI; LIPID ANALYSIS; MALE; METABOLOME; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL; SKINFOLD THICKNESS; TIME OF FLIGHT MASS SPECTROMETRY; UNIVARIATE ANALYSIS; VENOUS BLOOD; WEANING;

CEREALS; DOUBLE-BLIND METHOD; FATTY ACIDS, MONOUNSATURATED; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFANT; LACTOBACILLUS; LIPIDS; MALE; METABOLOME; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; PLASMA; PROBIOTICS; PUTRESCINE; REFERENCE VALUES; WEANING;

LACTOBACILLUS PARACASEI;

EID: 84879214066     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004618     Document Type: Article

References (52)

1. Vickers M (2011) Developmental programming of the metabolic syndrome-critical windows for intervention. World J Diabetes 2, 137-148.
2. Ogden CL, Carroll MD, Kit BK, et al. (2012) Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 307, 483-490.
3. Huh SY, Rifas-Shiman SL, Taveras EM, et al. (2011) Timing of solid food introduction and risk of obesity in preschool-aged children. Pediatrics 127, E544-E551.
4. Moorcroft KE, Marshall JL & McCormick FM (2011) Association between timing of introducing solid foods and obesity in infancy and childhood: a systematic review. Mater Child Nutr 7, 3-26.
5. Owen CG, Whincup PH, Kaye SJ, et al. (2008) Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative reviewof theevidence.AmJClinNutr 88,305-314.
6. Delzenne NM, Neyrinck AM, Bäckhed F, et al. (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7, 639-646.
7. Adlerberth I & Wold AE (2009) Establishment of the gut microbiota in Western infants. Acta Paediatr 98, 229-238.
8. Delzenne NM & Cani PD (2011) Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31, 15-31.
9. Ley RE, Bäckhed F, Turnbaugh P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102, 11070-11075.
10. Kalliomäki M, Salminen S & Isolauri E (2008) Positive interactions with the microbiota: probiotics. Adv Exp Med Biol 635, 57-66.
11. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
12. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Trans Med 1, 6ra14.
13. Kalliomäki M, Collado MC, Salminen S, et al. (2008) Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87, 534-538.
14. FAO/WHO (2001) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria Cordoba, Argentina ftp.fao.org/es/esn/food/probio-report-en.pdf.
15. Laitinen K, Collado M & Isolauri E (2010) Early nutritional environment: focus on health effects of microbiota and probiotics. Benef Microbes 1, 383-390.
16. Ooi LG & Liong MT (2010) Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11, 2499-2522.
17. Nerstedt A, Nilsson EC, Ohlson K, et al. (2007) Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 97, 1117-1127.
18. Aronsson L, Huang Y, Parini P, et al. (2010) Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5, e13087.
19. Fiehn O (2002) Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 48, 155-171.
20. Kell DB (2004) Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol 7, 296-307.
21. Wang ZN, Klipfell E, Bennett BJ, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63.
22. Brennan L (2008) Metabolomic applications in nutritional research. Proc Nutr Soc 67, 404-408.
23. West CE, Gothefors L, Granström M, et al. (2008) Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 19, 53-60.
24. The International Response to Helsinki V (2000) The WMA's Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects, As Adopted by the 52nd WMA General Assembly. Edinburgh. www.wma.net/en/20 activities/10ethics/10helsinki/intl-response-helsinki.pdf
25. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
26. Wishart DS, Tzur D, Knox C, et al. (2007) HMDB: the humanmetabolome database.NucleicAcids Res 35,D521-D526.
27. Wiklund S, Johansson E, Sjöström L, et al. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80, 115-122.
28. Kunesova M, Hainer V, Tvrzicka E, et al. (2002) Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids 37, 27-32.
29. Paillard F, Catheline D, Le Duff F, et al. (2008) Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. Nutr Metab Cardiovasc Dis 18, 436-440.
30. Okada T, Furuhashi N, Kuromori Y, et al. (2005) Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 82, 747-750.
31. Lands WE (1995) Long-term fat intake and biomarkers. Am J Clin Nutr 61, S721-S725.
32. Sen B, Bose K, Shaikh S, et al. (2010) Prediction equations for body-fat percentage in Indian infants and young children using skinfold thickness and mid-arm circumference. J Health Popul Nutr 28, 221-229.
33. Guo Z, Liu XM, Zhang QX, et al. (2011) Influence of consumption of probiotics on the plasma lipid profile: a metaanalysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 21, 844-850.
34. Norin E & Midtvedt T (2006) In born germfree-microbioal dependent. In Gastrointestinal Microbiology, pp. 273-284 [AC Ouwehand and EE Vaughan, editors]. New York, NY: Taylor & Francis.
35. Edwards CA & ParrettAM (2002) Intestinal flora during the first months of life: new perspectives. Br J Nutr 88, S11-S18.
36. Alliet P, Scholtens P, Raes M, et al. (2007) Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition 23, 719-723.
37. Uauy R & Dangour AD (2009) Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab 55, 76-96.
38. McCormack SA&Johnson LR (1991) Role of polyamines in gastrointestinal mucosal growth. Am J Physiol 260, G795-G806.
39. Pegg AE (2009) Mammalian polyamine metabolism and function. IUBMB Life 61, 880-894.
40. Löser C (2000) Polyamines in human and animal milk. Br J Nutr 84, S55-S58.
41. Larqué E, Sabater-Molina M & Zamora S (2007) Biological significance of dietary polyamines. Nutrition 23, 87-95.
42. Rosenfeldt V, Benfeldt E, Valerius NH, et al. (2004) Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145, 612-616.
43. Berg JT, Tymoczko JL & Stryer L (2002) Biochemistry, 5th ed., pp. 563-568 [S Moran, editor]. New York, NY: W.H. Freeman.
44. Kullisaar T, Zilmer M, Mikelsaar M, et al. (2002) Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 72, 215-224.
45. van de Guchte M, Penaud S, Grimaldi C, et al. (2006) The complete genome sequence of Lactobacillus bulgaricus reveals extensive and ongoing reductive evolution. Proc Natl Acad Sci USA 103, 9274-9279.
46. Chattopadhyay MK, Tabor CW & Tabor H (2003) Polyamines protect Escherichia coli cells from the toxic effect of oxygen. Proc Natl Acad Sci USA 100, 2261-2265.
47. Fujita T, Fujita M, Kodama T, et al. (2003) Determination of Dand L-pipecolic acid in food samples including processed foods. Ann Nutr Metab 47, 165-169.
48. He M (2006) Pipecolic acid in microbes: biosynthetic routes and enzymes. J Ind Microbiol Biotechnol 33, 401-407.
49. Eckburg PB, Bik EM, Bernstein CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
50. Lind T, HernellO, Lönnerdal B, et al. (2004) Dietary iron intake is positively associated with hemoglobin concentration during infancy but not during the second year of life. J Nutr 134, 1064-1070.
51. Hammarqvist F, Angsten G, Meurling S, et al. (2010) Agerelated changes of muscle and plasma amino acids in healthy children. Amino Acids 39, 359-366.
52. Lepage N, McDonald N, Dallaire L, et al. (1997) Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem 43, 2397-2402. Spatial Planning (FORMAS)